Can the blood collection needle be reused?

No, the blood collection needle can only be used once and must be disposed of in a medical trash bin.

What is the lead time for orders?

Peak season lead time is one month, while off-season lead time is within 15 workdays.

Advanced Blood Glucose Meter for Accurate Diabetes Monitoring

Name: Advanced Blood Glucose Meter for Accurate Diabetes Monitoring
Brand: Contiwin Co., Ltd
SKU: 2307239435

Shanghai, ChinaContiwin Co., Ltd

US$3.90-7.90

100 Pieces

Sample price:US$10.00/piece.Request sample

Product profile

Customization

Available

Type

Test Strips & Test Tube

Material

Plastic

Model NO.

A, B, C, D

Ethylene Oxide Sterilization

Without Ethylene Oxide Sterilization

Quality Guarantee Period

10 Years

Group

Adlut,Children

Logo Printing

With Logo Printing

Applicable Scenarios

Family

Sample

Whole Blood From Fingertip Capillaries

Product Type

Blood Testing Equipments, Blood Analysis System

Usage Pattern

External Use

Transport Package

Carton

Specification

30*45*10

Trademark

OEM ODM

Origin

China

HS Code

9018909919

Production Capacity

50000PCS/Day

Key features

Fast Blood Glucose Testing: Results displayed in just 7 seconds after applying a blood sample.

Long Quality Guarantee: Comes with a 10-year quality guarantee period for reliability.

OEM and ODM Services: Supports logo printing and custom branding for manufacturers.

Self-Testing Design: Designed for individuals to monitor diabetes control effectiveness at home.

Wide Age Group Support: Suitable for both adults and children for diabetes monitoring.

Multiple Calibration Options: Available with self-calibration or manual calibration card options.

Flexible Lead Time: Off-season delivery within 15 workdays; peak season within one month.

Company profile

Contiwin Co., Ltd

Shanghai, China

Business Type: Manufacturer/FactoryAverage Response Time: ≤0.22h

AI-Powered supplier vetting

SummaryContiwin Co., Ltd is a China-based limited company established in 2020 and identified as a trading company, with an export license and export sales share of 71%–90%. The supplier reports more than 10 production lines, 31–40 quality-control staff, and stated output for hemodialyser flux and A-V blood lines, but other data identifies only three total employees and zero cooperative suppliers, creating internal consistency concerns. Lead times are within 15 workdays in both peak and off-season periods. Overseas infrastructure is limited to participation in an offline medical equipment exhibition; no overseas warehouses, showrooms, agents, branches, or service countries are reported. Quality-system evidence is incomplete: test equipment is listed as zero, complaint procedures and service corrective-action procedures are absent, and quality assurance and traceability status are unknown. No new products, ODM, OEM for popular brands, or SDK are reported. Financial-capacity records are present for multiple years,...

Supplier typeThe supplier is identified as Contiwin Co., Ltd, a China-based limited company established in 2020 and classified as a trading company. Its stated business scope includes medical instruments, production, and import-export services, while no larger-company affiliation is reported.

CertificationsThe supplier explicitly reports holding a valid import and export license. No other certification, quality-system certificate, or product certification is identified in the provided slices, so the assessment is limited to export licensing.

After-Sales capabilityThe supplier reports no written customer-complaint procedures or records, no written service-capability assessment or corrective-action procedures, and no overseas warehouses, showrooms, agents, branches, or service countries. It has participated in one offline medical equipment exhibition and reports lead times within 15 workdays, but these do not establish strong after-sales support.

R&D capabilityThe supplier reports one R&D engineer whose stated responsibility is providing samples to customer requirements. It reports no new products in the past year, no ODM service, no OEM for popular brands, and no available SDK, indicating limited demonstrated innovation capability.